Studies have identified AMPK-dependent lipophagy as a therapeutic target for NAFLD in exercise treatment16, and MIF/AMPK signalling activation has been shown as a mechanism by which exercise prevents NAFLD17. Here, MIF is linked to metabolic dysfunction-associated steatotic liver disease.